Highest-materiality recent filing
Nasdaq Hearings Panel granted conditional listing continuation; trading suspended since April 14, 2026 for bid price non-compliance.
SCWorx receives Nasdaq delisting notice; effects 1-for-15 reverse stock split
Nasdaq notified SCWorx on April 7, 2026, of delisting for failing to maintain $1 minimum bid price; trading suspended April 14, 2026.
SCWorx implements 1-for-15 reverse stock split to meet Nasdaq $1.00 minimum bid price rule
Certificates amended to effect 1-for-15 reverse split; effective at open on April 10, 2026.
SCWorx shareholders approve 8 proposals including massive authorized share increase to 155M
Shareholders approved increase in authorized shares from 50M to 155M (150M common, 5M preferred).
SCWorx receives 180-day Nasdaq extension to regain $1 bid price compliance
Nasdaq granted 180-day extension to April 6, 2026 to regain minimum $1 bid price compliance; previously notified April 16, 2025.
SCWorx raises ~$722k via warrant exercise inducement; issues new warrants for 4.13M shares
Existing warrant holders exercised 2,064,000 shares at $0.3496, generating gross proceeds of ~$721,574.
SCWorx Corp receives Nasdaq delisting notice for bid price below $1
Nasdaq notified SCWorx on April 10, 2025 that bid price below $1 for 30 consecutive days violates Nasdaq Rule 5550(a)(2).
SCWorx raises $1.5M via secured convertible notes and warrants
Issued $1.5M senior secured convertible notes (10% interest, maturity Jan 21, 2027) to accredited investors.
SCWorx shareholders approve reverse stock split authorization up to 1:15
All 8 proposals passed at Dec 23, 2024 annual meeting; directors elected with >90% support.
SCWorx receives Nasdaq delisting notice for missed Q2 2024 10-Q; extension to Oct 14
Nasdaq notified SCWorx on Aug 19, 2024 of non-compliance with Listing Rule 5250(c)(1) for failure to file Q2 2024 10-Q.
Aggregate $1,155,000 principal in senior secured convertible notes sold to accredited investors; initial conversion price $1.43/share.
Promissory note of $330K face ($300K cash), 5% interest, secured by all assets, maturity extended weekly to July 12, 2024.
SCWorx extends promissory note maturity to June 14; faces $502K arbitration judgment
Note $330K face ($300K cash), 5% interest, secured; maturity extended repeatedly from May 10 to June 14, 2024.
SCWorx extends promissory note maturity to May 31 after repeated short extensions
Note originally issued April 12, 2024 for $330,000 face, net proceeds $300,000 after $30,000 OID.
SCWorx receives Nasdaq delisting notice, appoints new auditor, extends debt maturity
Nasdaq notified SCWorx of non-compliance with Listing Rule 5250(c)(1) due to failure to file 10-Q and 10-K.
On May 7, 2024, board terminated BF Borgers as auditor after SEC barred them from practicing on May 3, 2024.
Nasdaq notified SCWorx on Apr 17, 2024 for failure to file 10-K by Apr 15 extended due date; company working to complete audit.
SCWorx and American Environmental mutually terminate merger agreement
On March 26, 2024, SCWorx and American Environmental agreed by mutual consent to terminate the Merger Agreement dated December 22, 2023.
SCWorx subsidiary to merge with American Environmental; AEPT will be the surviving entity.
SCWorx enters LOI for reverse merger with American Environmental; arbitration award of $462K
SCWorx and American Environmental (OTC:AEPT) sign LOI for reverse merger; SCWorx shareholders to retain 17% after $6M capital raise by AEPT.
SCWorx implements 1-for-15 reverse stock split to regain Nasdaq minimum bid price compliance
Stockholders approved a 1-for-15 reverse stock split on October 6, 2023; effective October 11, 2023.
Nasdaq panel grants SCWorx continued listing subject to reverse split and bid price deadline Oct 20
On Aug 1, 2023, Nasdaq hearings panel granted SCWorx continued listing subject to conditions to regain Bid Price Rule compliance.
SCWorx issues 1.94M shares to settle suit; Nasdaq delisting notice for bid non-compliance
Issued 1,941,858 shares of common stock to satisfy $600,000 class-action settlement liability.
SCWorx raises $750k through issuance of 1,153,847 common shares at $0.65/share
Issued 1,153,847 common shares at $0.65 per share to accredited investors on Sept 1, 2022.
SCWorx enters $5M common stock purchase agreement with institutional investor
Up to $5M of common stock may be sold over 24-month term at Company's option.
SCWorx receives Nasdaq notice of non-compliance with $1 minimum bid price
Nasdaq notified SCWorx on June 8, 2022 that its closing bid price was below $1 for 30 consecutive business days, violating Rule 5550(a)(2).
SEC charged SCWorx and former CEO Schessel with false/misleading statements about COVID-19 rapid test kit distribution in April 2020.
SCWorx files auditor response letter regarding non-reliance on prior financials
Sadler Gibb letter confirms auditor change and non-reliance on previously issued financial statements.
Settlement of three derivative lawsuits filed in 2020 alleging breach of fiduciary duties related to COVID-19 test kit press release.
SCWorx settles securities class action; to issue $600K in stock to plaintiffs
Company and former CEO Marc Schessel settle consolidated securities class action filed in 2020 over COVID-19 test kit statements.
SCWorx receives Nasdaq delisting notice over committee composition after director resignation
Nasdaq notified SCWorx on July 16, 2021 of non-compliance with Rule 5605 due to lack of 3-member Audit Committee and 2-member Compensation Committee.
Mr Kirchenbauer was appointed Chairman of the board, to serve in such capacity until the next annual meeting of shareholders.
On October 31, 2024, Alton Irby and Steven Horowitz, resigned from the Board of Directors and from their positions as members of the Audit, Compensation and Nominating and Corporate Committees of SCWorx Corp (the “Company”).
On October 31, 2024, Michael Burke and Troy Kirchenbauer were appointed to the Board of Directors of SCWorx, Corp., a Delaware corporation.
On October 31, 2024, Alton Irby and Steven Horowitz, resigned from the Board of Directors and from their positions as members of the Audit, Compensation and Nominating and Corporate Committees of SCWorx Corp (the “Company”).
On August 17, 2023, the Board of Directors appointed Vincent M. Matozzo, an individual, as an independent member of the Board of Directors, effective immediately,
On August 18, 2023, the board of directors (the “Board of Directors”) of SCWorx Corp. (the “Company”) received the resignation of John Ferrara, as an independent, outside director of the Company.
Alton Irby was appointed Chairman of the board, to serve in such capacity until the next annual meeting of shareholders.
On August 11, 2021, John Ferrara and Steve Horowitz were appointed to the Board of Directors of SCWorx, Corp., a Delaware corporation (the "Company").
On August 11, 2021, John Ferrara and Steve Horowitz were appointed to the Board of Directors of SCWorx, Corp., a Delaware corporation (the "Company").
Effective June 25, 2021, Mark D. Shefts resigned as a director of SCWorx, Corp., a Delaware corporation, including his positions as Chairman of the Board and Audit Committee and member of the Compensation and Nominating Committees.
Max materiality 0.90 · Median 0.65 · Most common event other_material